Successful twin pregnancy while on cyclophosphamide therapy in a patient with lupus nephritis

Rheumatology International

Volumn 29, Issue 12, 2009, Pages 1503-1505

  Gupta, Rajiva ^a   Deepanjali, S ^a   Thabah, M M ^a   Kaur, P ^a   Gupta, S ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b MAULANA AZAD INSTITUTE OF DENTAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE;

ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; TWIN PREGNANCY;

CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; TWINS; YOUNG ADULT;

EID: 69049118335     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-0860-4     Document Type: Article

References (15)

1. AD Steinberg SC Steinberg 1991 Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only Arthritis Rheum 34 945 950 10.1002/art.1780340803
2. CL Wang F Wang JJ Bosco 1995 Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus Lupus 4 11 14 10.1177/ 096120339500400103
3. DT Boumpas HA Austin EM Vaughan, et al. 1993 Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy Ann Intern Med 119 366 369
4. GM Enns E Roeder RT Chan, et al. 1999 Apparent cyclophosphamide (Cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 86 237 241 10.1002/(SICI)1096-8628(19990917)86:3〈237::AID-AJMG8〉3.0.CO;2-V
5. G Koren A Pastuszak S Ito 1998 Drugs in pregnancy N Engl J Med 338 1128 1137 10.1056/NEJM199804163381607
6. HA Austin JH Klippel JE Balow, et al. 1986 Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 614 619
7. MC Park YB Park SY Jung, et al. 2004 Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy Lupus 13 569 574 10.1191/0961203304lu1063oa
8. DL Huong Z Amoura P Duhaut, et al. 2002 Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients J Rheumatol 9 2571 2576
9. MM Medeiros VA Silveira AP Menezes, et al. 2001 Risk factors for ovarian failure in patients with systemic lupus erythematosus Braz J Med Biol Res 34 1561 1568 10.1590/S0100-879X2001001200008
10. CC Mok CS Lau RW Wong 1998 Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy Arthritis Rheum 41 831 837 10.1002/1529-0131(199806)41:6〈1090::AID-ART16〉3.0. CO;2-6
11. GE Katsifis AG Tzioufas 2004 Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide Lupus 13 673 678 10.1191/0961203304lu2012oa
12. Y Matsukawa S Nishinarita T Horie, et al. 1998 Successful child bearing during intravenous cyclophosphamide therapy in a patient with systemic lupus erythematosus Br J Rheumatol 37 342 343 10.1093/rheumatology/37.3.342
13. H Kart Koseoglu AE Yucel G Kunefeci, et al. 2001 Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy Lupus 10 818 820 10.1177/096120330101001110
14. ME Clowse L Magder M Petri 2005 Cyclophosphamide for lupus during pregnancy Lupus 14 593 597 10.1191/0961203305lu2169oa
15. D Zemlickis M Lishner R Erlich, et al. 1993 Teratogenicity and carcinogenicity in a twin exposed in utero to cyclophosphamide Teratog Carcinog Mutagen 13 139 143 10.1002/tcm.1770130304